AnaSCI - Fitness Evolved

Buy Needles and Syringes with NO PRESCRIPTION   Synthetek Muscle Building And Fat Loss Products   Cheap Pure Supplements


  Synthetek Syntherol  
Largest Selection of Bodybuilding Products   Largest Selection of Bodybuilding Products   Largest Selection of Bodybuilding Products

User CP FAQ Members List Calendar New Posts Quick Links Log Out

AnaSCI Fitness Evolved  AnaSCI Fitness Evolved  AnaSCI Fitness Evolved  AnaSCI Fitness Evolved  AnaSCI Fitness Evolved


Automatic Translations (Powered by Yandex):
Albanian Belarusian Catalan Czech Danish Dutch English Estonian Finnish French German Greek Hungarian Italian Latvian Lithuanian Macedonian Norwegian Portuguese Russian Slovak Slovenian Spanish Swedish Turkish Ukrainian

Go Back   Anabolic Steroids Discussion and Bodybuilding Forum > Anabolic Science Section > Anabolic Science Forum

Thread Tools Display Modes
Myostatin blockers: Think its real???
tee's Avatar
Posts: 4,130
Join Date: Feb 2004
Location: USA
Myostatin blockers: Think its real??? - 03-14-2005, 12:27 PM

New "Mighty Mice" Research Brings Muscle Growth Closer To Reality

The Johns Hopkins scientists who first created "mighty mice" by genetically engineering animals with a missing growth regulator called myostatin have now created a second group of mice whose genetic makeup shows itís possible to get the same effect by blocking the gene for myostatin, rather than entirely knocking it out.

Reporting in the July 16 issue of the Proceedings of the National Academy of Sciences, the researchers say they have identified several proteins (follastatin, mutant activin type II receptors, and myostatin propeptide) that can block the activity of myostatin. Moreover, they have engineered mice with normal myostatin, but various levels of these blockers.

"By expressing high levels of these proteins in mice, we have been able to increase muscle mass to levels comparable to those seen in mice completely lacking myostatin," says Se-Jin Lee, M.D., Ph.D., lead author of the Hopkins study. "Although more study is needed to prove that these mice are good models for humans and to find other myostatin signaling components, our work suggests that these kinds of myostatin antagonists may be effective muscle-enhancing agents for both human and agricultural applications."

The 1997 report from Lee and his colleagues focused on the muscle-building capability of knocking out, or deleting the myostatin gene, to allow the buildup of skeletal muscle in the animals.

"Until now, it's been purely theoretical that we could block the gene and obtain the same muscle-building effect as deleting the gene," Lee continues.

The researchers discovered that while mice that were engineered to produce large amounts of follistatin exhibited the most herculean muscles, the other two groups, one with excess mutant activin II receptors and one with myostatin peptide, also showed increased muscle growth.

Scientists are hopeful that the finding will provide new opportunities to treat many muscle-wasting diseases like muscular dystrophy or cachexia, the muscle loss that accompanies some cancers and AIDS. Blocking myostatin in animals could also create livestock with more meat and relatively less fat.

"The agricultural applications are probably more straightforward, since conceivably, one could try to find ways to block myostatin activity early during development," says Lee. "For human applications, this research is just the beginning."

Among the important remaining questions is whether blocking myostatin postnatally, as would be required to treat human diseases, is effective. "These proteins all block myostatin outside the cell, so we need to see if administering these proteins, rather than altering the genome, can provide similar results," he explains.

The other author of the study is Alexandra McPherron, Ph.D., from Hopkins. The study was funded by the National Institutes of Health. Myostatin was licensed to MetaMorphix, which was founded by Lee in 1995. The company was established to commercialize on work by Hopkins and Genetics Institute, a private pharmaceutical company, in the field of growth and differentiation factors. Myostatin is sublicensed to American Home Products and Cape Aquaculture Technologies (CAT). The authors are entitled to a share of sales royalty received by the University for sales of this factor. The authors and the University own MetaMorphix stock; the authors also own CAT stock. Both stocks are subject to certain restrictions under University policy. Lee is a consultant to MetaMorphix and CAT, and McPherron is a consultant to CAT. The terms of these arrangements are being managed by the University in accordance with its conflict-of- interest policies
Reply With Quote
tee's Avatar
Posts: 4,130
Join Date: Feb 2004
Location: USA
03-14-2005, 12:27 PM

Photos of the mice tested.
Reply With Quote
Oracle's my Mod
Bizarro's Avatar
Posts: 449
Join Date: Aug 2004
Location: Toxic Dump
03-14-2005, 12:39 PM

Good info tee - thanks. So this is how the US will breed our super-soldiers of the future....

Now could you get back to posting some porn -- this stuff is too intellectual....

If you think education is expensive try ignorance.

Last edited by Bizarro; 03-14-2005 at 12:41 PM.
Reply With Quote

Thread Tools
Display Modes

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off

Forum Jump

All times are GMT -4. The time now is 04:29 PM.

Copyright © 2003-2019 All rights reserved.